These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27582427)

  • 1. Clonal cooperativity in heterogenous cancers.
    Zhou H; Neelakantan D; Ford HL
    Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
    Marusyk A; Janiszewska M; Polyak K
    Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers.
    Cleary AS; Leonard TL; Gestl SA; Gunther EJ
    Nature; 2014 Apr; 508(7494):113-7. PubMed ID: 24695311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data.
    Lee ND; Kaveh K; Bozic I
    Semin Cancer Biol; 2023 Jul; 92():61-73. PubMed ID: 37023969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.
    Lyons JG; Lobo E; Martorana AM; Myerscough MR
    Clin Exp Metastasis; 2008; 25(6):665-77. PubMed ID: 18071912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of clonal communication and heterogeneity in breast cancer.
    Martín-Pardillos A; Valls Chiva Á; Bande Vargas G; Hurtado Blanco P; Piñeiro Cid R; Guijarro PJ; Hümmer S; Bejar Serrano E; Rodriguez-Casanova A; Diaz-Lagares Á; Castellvi J; Miravet-Verde S; Serrano L; Lluch-Senar M; Sebastian V; Bribian A; López-Mascaraque L; López-López R; Ramón Y Cajal S
    BMC Cancer; 2019 Jul; 19(1):666. PubMed ID: 31277602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of intratumor heterogeneity: challenges and opportunities.
    Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
    J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.
    Marusyk A; Tabassum DP; Altrock PM; Almendro V; Michor F; Polyak K
    Nature; 2014 Oct; 514(7520):54-8. PubMed ID: 25079331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation.
    Ohsawa S; Takemoto D; Igaki T
    J Biochem; 2014 Sep; 156(3):129-36. PubMed ID: 25012819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering intratumor heterogeneity using cancer genome analysis.
    Ryu D; Joung JG; Kim NK; Kim KT; Park WY
    Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
    McGranahan N; Swanton C
    Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor heterogeneity: causes and consequences.
    Marusyk A; Polyak K
    Biochim Biophys Acta; 2010 Jan; 1805(1):105-17. PubMed ID: 19931353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor genetic heterogeneity].
    Yang YL; Chu JY; Wang MR
    Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
    Gerlinger M; Swanton C
    Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.